Over the course of the past year or so, there have been many companies that have seen their stocks soar on the back of their work regarding COVID-19 treatments. One such company is Sunshine Biopharma, Inc. (OTC: SBFM), which saw its stock rally strongly after it made a key announcement about such a product.
The company announced yesterday that it has started a transgenic mice study for its COVID 19 treatment and that resulted in a strong rally in the stock. That being said, it should be noted that the stock has been on a strong run over the course of the past month. During that period, the Sunshine stock has managed to deliver gains of as high as 1150% and it is perhaps time to start tracking it a bit more closely.
The COVID 19 treatment in question is all about series of molecules that try to stop the multiplication of the virus. It is likely that investors are going to be tracking the developments regarding the latest study quite closely.
Biotech, Tech, and Crypto reporter
Anthony Gonzales brings 3 years of experience in helping grassroots, mid-sized organizations and large institutions strengthen their management and resource generating capacities and effectively plan for the future. He is also a mentor and professional advisor to artists working in all disciplines. He is the gold medalist from St. Marco University of Science and Technology in the Bachelors of Financial Management as well.